Ask the Expert: Blood-Brain-Barrier

What is the Blood-Brain-Barrier, what is its function and how does the Blood-Brain-Barrier affect the treatment of brain tumours?

The brain is a very unique organ with a specialized barrier that selectively restricts the movement of substances from the blood into the brain. This barrier is comprised of the endothelial cells that form the lining of blood vessel capillaries and astrocytes which come in contact with the blood vessels.

In contrast to organs where the endothelial cells are loosely arranged, brain endothelial cells have a very tightly arranged conformation which forms the physical basis of the Blood-Brain-Barrier (BBB). This barrier limits the movement of certain substances from the blood into the brain while allowing others. The BBB restricts molecules that are either large, highly charged or have low lipid solubility.

In some instances, substances that do not meet the above criteria such as glucose can still be transported into the brain by specialized proteins. There are also specialized proteins such as the multidrug resistant (MDR) proteins which would actively pump some drugs out of the brain after crossing the BBB. In terms of function, the BBB serves a very protective role by selectively excluding potentially harmful chemicals as well as maintaining a stable environment conducive for brain function. However, the BBB integrity can be compromised in certain conditions such as exposure to toxic substances, severe hypertension, brain injury, brain infections or tumors which can result in swelling and impairment of brain function.

The BBB clearly presents a significant challenge in the treatment of brain tumours with chemotherapy. Most systemically administered chemotherapy agents do not readily cross the BBB because of the physical restrictions of the BBB. The MDR protein further limits availability of chemotherapy within the brain. Hence strategies to temporally disrupt the Blood-Brain-Barrier either by physical or chemical mechanisms have been investigated as a means to improve delivery of chemotherapy into the brain. In addition, blocking the MDR protein with drugs such as verapamil is one strategy to increase the amount of chemotherapy delivered into the brain.

Most recently, there has been a focus on nanotechnology – whereby particle clusters at the atomic scale can be engineered to deliver drugs across the BBB by mechanisms designed to overcome the physical and chemical restrictions of the BBB. The preliminary results of this new technology appear promising and could have significant implications for both the diagnosis and treatment of brain tumours.

Help patients and families affected by a brain tumour by making a gift today.
You can download this information as a Brain Tumour Foundation of Canada Information Sheet (pdf). 

A special thank you to Dr. James Rutka for taking the time to answer this important question. Dr. Rutka is a Professor for the Department of Laboratory Medicine and Pathobiology and Chairman of Division of Neurosurgery for the University of Toronto and Co-director of the Labatt Brain Tumour Research Centre at the Hospital for Sick Kids.

Dr. Rutka was awarded a 2009 Research Grant from Brain Tumour Foundation of Canada for his project entitled “Characterization of nanoparticle delivery across the blood brain barrier”. Dr. Rutka also volunteers for Brain Tumour Foundation of Canada as a member of our Professional Advisory Group.

 

Return to Information Sheets here.

Share This

Featured Story

Courtney’s Story of Stability

Stability. It’s a strange concept when you have what it known to be a progressive, life long illness. You hear the words, “Your tumour growth is stable” and for a moment you think someone is playing the world’s worst prank on you.

Learn more

Spotlight

Stephen's Story: "I have faith that we will meet again"

Stephen and I chatted on what should have been his 32nd Wedding Anniversary. Stephen and Susan were married for 30 years and were best...

Learn more

Tommy's Story: Fellowship recipient

Dr. Tommy Alain, the very first research Fellow funded by Brain Tumour Foundation of Canada through the William Donald Nash Brain...

Learn more

Upcoming Events

  • 16/Jan/2018: North Bay Support Group: Meets at St. Luke's Catholic Elementary School, 225 Milani Road, North Bay.... Learn more >
  • 16/Jan/2018: New Glasgow Support Group: Meets at East Haven Manor, 695 East River Road in New Glasgow, NS ... Learn more >
  • 17/Jan/2018: Windsor Support Group: Meets at the United Way, Unit A1, 300 Giles Blvd. East... Learn more >
  • 17/Jan/2018: Calgary Support Group: Meets at Wellspring Calgary, 1404 Home Road NW, Calgary, Alberta, T3B 1G7... Learn more >
View All Events >
Thank you to the donors whose contributions make this website and all programs, services and research possible.

Copyright © 2018 Brain Tumour Foundation of Canada. Charitable Registration #BN118816339RR0001
35 Years